1. Skip to content
  2. Skip to main menu
  3. Skip to more DW sites
ScienceGlobal issues

What's in store for mRNA technology after COVID?

02:27

This browser does not support the video element.

Derrick Wiliams
February 4, 2023

The first vaccines approved during the COVID-19 pandemic were based on a novel platform: messenger RNA. As the field of RNA-based technology matures, researchers are now hopeful it will also prove a powerful weapon in the fight against other diseases.

Skip next section DW's Top Story

DW's Top Story

Skip next section More stories from DW